5B New Diagnostics for STIs and Antimicrobial Resistant Gonorrhea

Earn CE Credit for viewing the archived recordings of the 2012 STD Conference.

Deadline: April 12, 2014

For details, click Continuing Education Information

Thursday, June 12, 2014: 8:00 AM-9:10 AM
Dogwood A

8:00 AM
Performance of New Point-of-Care Syphilis Tests
Kristen Hess, PhD, Dennis Fisher, PhD and Grace Reynolds, DPA, Center for Behavioral Research and Services, California State University Long Beach, Long Beach, CA
8:10 AM
Evaluating 4th Generation Testing for HIV-1 within a Non-Profit Setting
Mark McGrath, MPH1, Mena Gorre, MPH2, Jeffrey Klausner, MD, MPH3, Adam Cohen, MPH4, Gabriel Previtera, DIS1 and Claire C Bristow, MSc5, 1Public Health Division, AIDS Healthcare Foundation, Los Angeles, CA, 2Linkage to Care Director, AIDS Healthcare Foundation, Los Angeles, CA, 3Division of Infectious Diseases and Program in Global Health, David Geffen School of Medicine and Fielding School of Public Health, Los Angeles, CA, 4UCLA Fielding School of Public Health, Department of Community Health Sciences, University of California Los Angeles, Los Angeles, CA, 5Program in Global Health, UCLA, Los Angeles, CA
8:20 AM
In Vitro Synergy Testing of Two New Antimicrobial Combination Therapies for Gonorrhea
Olusegun Soge, PhD1, Lindley Barbee, MD, MPH2, Matthew Golden, MD, MPH3 and King Holmes, MD, PhD1, 1Neisseria Reference Laboratory, Center for AIDS and STD, Departments of Global Health and Medicine, University of Washington, Seattle, WA, 2Department of Medicine, Division of Allergy and Infectious Disease, University of Washington & Public Health -- Seattle & King County HIV/STD Program, Seattle, WA, 3Department of Medicine, Division of Allergy and Infectious Disease, and Public Health - Seattle & King County HIV/STD Program, University of Washington, Seattle, WA
8:30 AM
Intra-Laboratory Variability in the Etest® Method for Determining Antibiotic Susceptibility of Neisseria Gonorrhoeae to Cefixime, Ceftriaxone and Azithromycin
John Papp, PhD, Laboratory Reference and Research Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Marie-Claire Rowlinson, PhD, D(ABMM), Bureau of Public Health Laboratories, Jafar Razeq, Ph.D, HCLD (ABB), Maryland Department of Health, Baltimore, Maryland, Jason Wholehan, MT (ASCP), Michigan Department of Community Health, Lansing, Michigan, Anita Glennen, BS, Minnesota Department of Health, St. Paul, Minnesota, Chaney Walters, MS, MST, STD/Mycology, Mississippi Public Health Laboratories, Jackson, Mississippi, Jackson, MS, Peter Iwen, MS, PhD, D(ABMM), Nebraska Public Health Laboratory, Omaha, Nebraska, Lillian Lee, MS, SM(NRCM-ASCP), New York City Department of Health and Mental Hygiene, New York City, New York and Celia Hagan, MPH (CPH), Association of Public Health Laboratories, Silver Spring, Maryland
8:40 AM
Identification of Single Nucleotide Polymorphisms in Neisseria Gonorrhoeae Isolates with Elevated Cephalosporin MICs Using Next Generation Whole Genome Sequencing
Philip Links, PhD MSc MPA1, Irene Martin, BSc2, Matthew Links, PhD3, Qing Liu, PhD4, Ping Yan, PhD5, Jun Wu, PhD5 and Tom Wong, MD, MPH, FRCPC6, 1Professional Guidelines and Public Health Practice Division, Center for Communicable Diseases and Infection Control, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON, Canada, 2Streptococcus and STI Unit, National Microbiology Laboratory, Winnipeg, MB, Canada, 3Bio-Products and Bioprocessing, National Science Program, Science and Technology Branch, Agriculture and Agri-Food Canada, Agriculture and Agri-Food Canada, Saskatoon, SK, Canada, 4Translational Biosciences, Human Health and Therapeutics Portfolio, National Research Council of Canada, National Research Council of Canada, Ottawa, ON, Canada, 5Professional Guidelines and Public Health Practice Division, Center for Communicable Diseases and Infection Control, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Public Health Agency of Canada, Ottawa, ON, Canada, 6Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada
See more of: Oral and Poster